Epidermal growth factor prevents bacterial translocation in rats with acute pancreatitis
Dong Chen
Abstract
Dong Chen
Abstract
Objective: To evaluate the protective effect of epidermal growth factor (EGF) on intestinal barrier functionin rats with acute pancreatitis. Methods: Thirty-two male SD rats received injection of sodium taurocholate solution(3. 5 mg·L-1) into the pancreatic duct were randomly divided into control group (n=16) and treatment group (n=16). Animals incontrol group received total parenteral nutrition (TPN), animals in treatment group were fed on the same TPN formula ascontrol group and injections of EGF at a dose of 0. 2 mg' kg l' day--'. Rats were sacrificed on d 1 and d 5 of TPN. Concen-tration of xylose and fluorescein isothiocyanate (FITC)-dextran in superior mesenteric vein (SMV), protein and DNA contentin je junal mucosa were determined. Samples from SMV, mesenteric lymph nodes, pancreas, liver, spleen were harvested forcultures. Results: FITC-dextran concentration in treatment group was significantly lower than in control group [(3. 4±0. 7)vs (7. 5±0. 9) mg. L-1, P<0. 0l]. Protein and DNA content in je junal mucosa in treatment group were significantly higherthan in control group [(2. 65±0. 23) vs (1. 12±0. 18) mg· cm-1, (0. 25±0. 07) vs (0. 12±0. 04) mg·cm-1, P0. 01].Positive cultures in liver and spleen in treatment group were significantly lower than in control group (37.5 % vs 100%, 25%vs 100%, P0.05). Conclusion: EGF may prevent the increase of intestinal permeability and bacterial translocation duringTPN in rats with acute pancreatitis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To evaluate the protective effect of epidermal growth factor (EGF) on intestinal barrier functionin rats with acute pancreatitis. Methods: Thirty-two male SD rats received injection of sodium taurocholate solution(3. 5 mg·L-1) into the pancreatic duct were randomly divided into control group (n=16) and treatment group (n=16). Animals incontrol group received total parenteral nutrition (TPN), animals in treatment group were fed on the same TPN formula ascontrol group and injections of EGF at a dose of 0. 2 mg' kg l' day--'. Rats were sacrificed on d 1 and d 5 of TPN. Concen-tration of xylose and fluorescein isothiocyanate (FITC)-dextran in superior mesenteric vein (SMV), protein and DNA contentin je junal mucosa were determined. Samples from SMV, mesenteric lymph nodes, pancreas, liver, spleen were harvested forcultures. Results: FITC-dextran concentration in treatment group was significantly lower than in control group [(3. 4±0. 7)vs (7. 5±0. 9) mg. L-1, P<0. 0l]. Protein and DNA content in je junal mucosa in treatment group were significantly higherthan in control group [(2. 65±0. 23) vs (1. 12±0. 18) mg· cm-1, (0. 25±0. 07) vs (0. 12±0. 04) mg·cm-1, P0. 01].Positive cultures in liver and spleen in treatment group were significantly lower than in control group (37.5 % vs 100%, 25%vs 100%, P0.05). Conclusion: EGF may prevent the increase of intestinal permeability and bacterial translocation duringTPN in rats with acute pancreatitis.
Key concepts: Mesenteric lymph nodes, Acute pancreatitis, Spleen, Internal medicine, Epidermal growth factor, Pancreas, Fluorescein isothiocyanate, Pancreatitis